ArticleJournal of neurology2026
Non-motor symptoms burden and motor recovery following STN-DBS in Parkinson's disease: a data-driven longitudinal analysis.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSubthalamic nucleus-deep brain stimulation (STN-DBS) reliably improves cardinal motor symptoms in Parkinson's disease (PD). However, gait disorders and non-motor symptoms (NMS) may persist or emerge following surgery, diminishing quality of life and complicating clinical management.
objectivesTo characterize the dominant axes of clinical covariance across motor and non-motor domains before and after STN-DBS, and to determine whether non-motor symptom severity moderates post-DBS gait and mobility change.
methods100 PD patients undergoing STN-DBS (mean age 60.2 ± 7.6 years; 67% male) were studied. Principal component analysis (PCA) was performed on thirteen motor and non-motor sub-scores at pre-DBS, 1-year follow-up (1-y FU), and a subset (n = 33) at 3-5-year follow-up. Moderation was tested using analysis of covariance (ANCOVA): each 1-year motor outcome was regressed on its pre-DBS baseline, a non-motor moderator, and their interaction, adjusting for age and disease duration, with a significant interaction indicating that baseline non-motor severity was associated with the degree of subsequent motor recovery.
resultsPCA identified a core motor triad: gait, mobility, and freezing of gait as the primary source of clinical variance at all timepoints (PC1: 35% pre-DBS, declining to 28% at 3-5-y FU), PC1 was the only component to exceed a permutation null (p < 0.001), with memory-related impairment increased at longer-term follow-up. Moderation analysis showed that higher pre-operative mood burden specifically for psychomotor and psychosomatic symptoms were associated with poorer recovery of mobility (Psychomotor β = 1.16, p < 0.05). At 1-y FU anxiety and psychosomatic symptoms showed concurrent associations with mobility and overall motor burden (Anxiety β = 2.30, p < 0.05).
conclusionsSTN-DBS outcomes extend beyond global motor improvement and may be shaped by associations spanning the motor, cognitive, and mood domains. Higher NMS baseline burden was associated with poorer mobility recovery, and mood symptoms at follow-up were associated with concurrent motor burden. These exploratory findings support considering multi-domain pre-operative assessment and post-operative mood monitoring, as potential targets for optimizing motor outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.